FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Olmesartan Medoxomil Tablets
Status: Currently in Shortage
»Date first posted: 03/12/2019
»Therapeutic Categories: Cardiovascular

Expand all

Accord Healthcare Inc. (Revised 07/10/2019)

Company Contact Information:
866-941-7875

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5mg, 30T (NDC 1672-9320-10) Stocks available to support current customer demand; we are not in a position to support higher demand or new customers, due to limited API availability Estimated duration: December 2019 Limited API availability
5mg, 90T (NDC 1672-9320-15) Stocks available to support current customer demand; we are not in a position to support higher demand or new customers, due to limited API availability Estimated duration: December 2019 Limited API availability
20mg, 30T (NDC 1672-9321-10) Stocks available to support current customer demand; we are not in a position to support higher demand or new customers, due to limited API availability Estimated duration: December 2019 Limited API availability
20mg, 90T (NDC 1672-9321-15) Stocks available to support current customer demand; we are not in a position to support higher demand or new customers, due to limited API availability Estimated duration: December 2019 Limited API availability
40mg, 30T (NDC 1672-9322-10) Stocks available to support current customer demand; we are not in a position to support higher demand or new customers, due to limited API availability Estimated duration: December 2019 Limited API availability
40mg, 90T (NDC 1672-9322-15) Stocks available to support current customer demand; we are not in a position to support higher demand or new customers, due to limited API availability Estimated duration: December 2019 Limited API availability

Alembic Pharmaceuticals (Reverified 07/10/2019)

Company Contact Information:
908-393-9604

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5mg, Bottle of 30 counts (NDC 62332-131-30) Available
20mg, Bottle of 30 counts (NDC 62332-132-30) Available
20mg, Bottle of 90 counts (NDC 62332-132-90) Available
40mg, Bottle of 30 counts (NDC 62332-133-30) Available
40mg, Bottle of 90 counts (NDC 62332-133-90) Available

Alkem Laboratories (New 03/12/2019)

Company Contact Information:
201-476-9445

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Olmesartan Medoxomil 20mg 30 Tabs (NDC 67877-0446-30) Availability: TBD Other
Olmesartan Medoxomil 20mg 90 Tabs (NDC 67877-0446-90) Availability: TBD Other
Olmesartan Medoxomil 40mg 30 Tabs (NDC 67877-0447-30) Availability: TBD Other
Olmesartan Medoxomil 40mg 90 Tabs (NDC 67877-0447-90) Availability: TBD Other
Olmesartan Medoxomil 5mg 30 Tabs (NDC 67877-0445-30) Availability: TBD Other

Aurobindo Pharma (New 03/12/2019)

Company Contact Information:
866-850-2876

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5mg, 30 ct. (NDC 65852-0741-30) Availabe by 3/29/19 On Allocation API Supply Issue
20mg, 30 ct. (NDC 65862-0742-30) Available by 4/5/19 On Allocation API Supply Issue
20mg, 90 ct. (NDC 65862-0742-90) Available On Allocation API Supply Issue
40mg, 30 ct. (NDC 65862-0743-30) Available by 4/5/19 On Allocation API Supply Issue
40mg., 90 ct. (NDC 65862-0743-90) Available by 4/5/19 On Allocation API Supply Issue

Daiichi Sankyo, Inc. (Reverified 08/12/2019)

Company Contact Information:
908-992-7001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5mg, 30 Unit (NDC 65597-101-30) Available Other
20mg, 30 Unit (NDC 65597-103-30) Available Other
20mg, 90 Unit (NDC 65597-103-90) Available Other
40mg, 30 Unit (NDC 65597-104-30) Available Other
40mg, 90 Unit (NDC 65597-104-90) Available Other

Glenmark Pharmaceuticals (New 03/12/2019)

Company Contact Information:
888-721-7115

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5mg (NDC 68462-0436-30) Small quantity available (only half month of stock). Will be on out of stock by March end. Next availability only in mid-April API shortage
20mg (NDC 68462-0437-30) Out of stock. Will be out of stock until mid-April API shortage
20mg (NDC 68462-0437-90) Out of stock. Will be out of stock until mid-April API shortage
40mg (NDC 68462-0438-30) Out of stock. Will be out of stock until mid-April API shortage
40mg (NDC 68462-0438-90) Out of stock. Will be out of stock until mid-April API shortage

Mylan Pharmaceuticals Inc. (Revised 10/01/2019)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Olmesartan Medoxomil 5mg T 30s (NDC 0378-7012-93) Out of Stock. Resupply is Q1 2020.
Olmesartan Medoxomil 20mg T 30s (NDC 0378-7112-93) Out of Stock. Resupply is Q1 2020. Other
Olmesartan Medoxomil 20mg T 90s (NDC 0378-7112-77) Out of Stock. Resupply is Q1 2020. Other
Olmesartan Medoxomil 40mg T 30s (NDC 0378-7124-93) Out of Stock. Resupply is Q1 2020.
Olmesartan Medoxomil 40mg T 90s (NDC 0378-7124-77) Out of Stock. Resupply is Q1 2020. Other

Torrent Pharma Inc. (Reverified 06/10/2019)

Company Contact Information:
888-544-2299 option 4

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5mg tablet (NDC 13668-248-30) Available
20mg tablet (NDC 13668-249-30) Available
20mg tablet (NDC 13668-249-90) Available
40mg tablet (NDC 13668-250-30) Available
40mg tablet (NDC 13668-250-90) Available

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English